156
Participants
Start Date
September 18, 2025
Primary Completion Date
July 1, 2026
Study Completion Date
December 31, 2026
oral Lactobacillus johnsonii (1×10¹¹ CFU, twice daily)
Lactobacillus johnsonii, as a member of gut probiotics, has recently gained attention for its potential role in tumor immunotherapy due to its ability to modulate the immune system and maintain gut microbiota balance. Below is a summary of its possible mechanisms and applications: 1.Modulating Gut Microbiota and Immune Microenvironment. 2.Direct or Indirect Activation of Anti-Tumor Immunity. 3.Enhancing Efficacy of Immune Checkpoint Inhibitors (ICIs) . 4.Anti-Tumor Effects of Microbial Metabolites. 5.Preclinical and Clinical Research Progress.
Placebo
oral take placebo twice a day
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER